p53-武装瘤性病毒疗法通过抑制BCL-xL表达来改善软组织肉瘤中的辐射敏感性
Tadashi Komatsubara1, Hiroshi Tazawa2,3, Joe Hasei1
1Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Acta medica Okayama
|April 30, 2024
概括
这项研究表明,OBP-702与放射治疗相结合可增强癌细胞死亡,并抑制软组织肉瘤 (STS) 的瘤生长. 这种组合疗法为治疗STS患者提供了一个有前途的新策略.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 辐射瘤学 辐射瘤学
背景情况:
- 软组织肉瘤 (STS) 是一种罕见的,异质的癌症,通常对当前的治疗方法有抗性.
- 新的治疗策略对于改善STS患者的治疗结果至关重要.
- 瘤性腺病毒显示出作为癌症治疗药物的前景.
研究的目的:
- 评估OBP-702和电离辐射在人类STS细胞中的联合抗瘤作用.
- 调查这种组合疗法的协同效应背后的机制.
主要方法:
- 使用人类STS细胞系 (HT1080,NMS-2,SYO-1) 的体外和体内研究.
- 用OBP-702 (一种端粒酶特异性瘤性腺病毒) 和电离辐射治疗.
- 对亡,B细胞淋巴瘤-X大 (BCL-xL) 表达和瘤生长抑制的评估.
主要成果:
- OBP-702协同增强了对STS细胞的电离辐射的抗瘤作用.
- 组合疗法抑制了BCL-xL的表达,并增加了辐射诱导的亡.
- 在体内实验表明,结合疗法显著抑制了STS瘤生长.
结论:
- 与电离辐射相结合的OBP-702对STS具有显著的抗瘤活性.
- 这种组合策略有望提高辐射敏感性并改善STS患者的预后.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K


